[CMSB] QoQ TTM Result on 30-Jun-2014 [#2]

Stock
[CMSB] CAHYA MATA SARAWAK BHD
Announcement Date
27-Aug-2014
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2014
Quarter
30-Jun-2014 [#2]
Profit Trend
QoQ- 14.09%
YoY- 67.69%
Quarter Report
Latest QR
Upcoming QR
CMSB's Result
CMSB's Financial Summary
View:
Show?
TTM Result
31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 CAGR
Revenue 1,791,648 1,673,898 1,602,418 1,524,751 1,479,721 1,416,841 1,376,829 19.21%
PBT 370,271 341,452 377,760 336,107 306,272 294,894 248,525 30.47%
Tax -81,351 -75,844 -88,997 -83,918 -81,029 -79,346 -66,653 14.22%
NP 288,920 265,608 288,763 252,189 225,243 215,548 181,872 36.18%
-
NP to SH 239,862 221,335 242,731 211,344 185,241 175,072 144,885 39.98%
-
Tax Rate 21.97% 22.21% 23.56% 24.97% 26.46% 26.91% 26.82% -
Total Cost 1,502,728 1,408,290 1,313,655 1,272,562 1,254,478 1,201,293 1,194,957 16.52%
-
Net Worth 1,862,086 1,807,584 1,786,110 1,738,287 1,697,033 1,354,271 1,355,107 23.62%
Dividend
31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 CAGR
Div 88,239 88,239 56,148 56,148 57,217 57,217 55,693 35.94%
Div Payout % 36.79% 39.87% 23.13% 26.57% 30.89% 32.68% 38.44% -
Equity
31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 CAGR
Net Worth 1,862,086 1,807,584 1,786,110 1,738,287 1,697,033 1,354,271 1,355,107 23.62%
NOSH 1,040,271 1,038,841 1,038,436 1,034,694 339,406 338,567 338,776 111.40%
Ratio Analysis
31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 CAGR
NP Margin 16.13% 15.87% 18.02% 16.54% 15.22% 15.21% 13.21% -
ROE 12.88% 12.24% 13.59% 12.16% 10.92% 12.93% 10.69% -
Per Share
31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 CAGR
RPS 172.23 161.13 154.31 147.36 435.97 418.48 406.41 -43.60%
EPS 23.06 21.31 23.37 20.43 54.58 51.71 42.77 -33.78%
DPS 8.50 8.49 5.41 5.43 16.86 16.90 16.44 -35.60%
NAPS 1.79 1.74 1.72 1.68 5.00 4.00 4.00 -41.52%
Adjusted Per Share Value based on latest NOSH - 1,034,694
31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 CAGR
RPS 166.69 155.73 149.08 141.86 137.67 131.82 128.10 19.20%
EPS 22.32 20.59 22.58 19.66 17.23 16.29 13.48 40.00%
DPS 8.21 8.21 5.22 5.22 5.32 5.32 5.18 35.97%
NAPS 1.7324 1.6817 1.6617 1.6172 1.5789 1.26 1.2607 23.62%
Price Multiplier on Financial Quarter End Date
31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 CAGR
Date 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 -
Price 4.50 3.96 4.35 3.73 9.80 6.87 5.08 -
P/RPS 2.61 2.46 2.82 2.53 2.25 1.64 1.25 63.43%
P/EPS 19.52 18.59 18.61 18.26 17.96 13.29 11.88 39.28%
EY 5.12 5.38 5.37 5.48 5.57 7.53 8.42 -28.24%
DY 1.89 2.14 1.24 1.45 1.72 2.46 3.24 -30.20%
P/NAPS 2.51 2.28 2.53 2.22 1.96 1.72 1.27 57.55%
Price Multiplier on Announcement Date
31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 CAGR
Date 18/05/15 25/02/15 26/11/14 27/08/14 14/05/14 26/02/14 28/11/13 -
Price 5.37 4.29 4.45 4.19 9.86 7.51 5.90 -
P/RPS 3.12 2.66 2.88 2.84 2.26 1.79 1.45 66.74%
P/EPS 23.29 20.14 19.04 20.51 18.07 14.52 13.80 41.79%
EY 4.29 4.97 5.25 4.87 5.54 6.89 7.25 -29.54%
DY 1.58 1.98 1.22 1.30 1.71 2.25 2.79 -31.57%
P/NAPS 3.00 2.47 2.59 2.49 1.97 1.88 1.48 60.23%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment